Nycomed Distribution Ltd.,   

Cytokine
Lyophilizate for solution for intramuscular injection 30 μg / ml (6 million IU / ml).
Regeneration of tissue stimulant
Solution for infusions [in sodium chloride solution 0,9%] 4 mg / ml, 8 mg / ml.
Anticoagulant means of indirect action
Tablets of 2.5 mg.
Tocolytic agent - beta2-adrenomimetic selective
The solution for intravenous administration is 5 μg / ml.
Hypoglycemic agent for oral administration of the biguanide group
Long-acting tablets, 750 mg.
Psoriasis treatment

Cream for external use 0,005%.

Psoriasis treatment

Solution for external use 0,005%.

Vasodilator
Solution for intravenous and intramuscular injection.
Vasodilator
The coated tablets are 20 mg + 50 mg + 60 mg and 60 mg + 100 mg + 60 mg.
Thyroid agent

Tablets 0.100 mg / 0.131 mg.

Antiallergic agent - H1-histamine receptor blocker
Syrup, 1 mg / ml.
anticonvulsant - alpha-adrenomimetic

For 10 ml, 15 ml of the drug in a bottle of dark glass, equipped with a multi-dose sprayer with a tip and a protective cap made of polyethylene.

One bottle together with the instruction for use is placed in a cardboard box.

anticonvulsant - alpha-adrenomimetic

Nasal drops 0.05% and 0.1%.

For 10 ml of the drug in a bottle-dropper from low-density polyethylene. The bottle is closed with a screw cap made of polypropylene. One bottle together with the instruction for use is placed in a cardboard box.

anticonvulsant - a vasoconstrictor (alpha-adrenomimetic)

Form of issue. Spray nasal dosed with 35 μg / dose of 140 μg / dose.

For 10 ml of the drug (not less than 125 doses in the vial for dosing 35 mcg / dose; not less than 60 doses in vial for a dosage of 140 mcg / dose) in a plastic bottle equipped with pump metering device with a tip and a protective cap of polyethylene.

One bottle together with the instruction for use is placed in a cardboard box.

anticonvulsant.

Spray nasal dosed with 84 μg / dose + 70 μg / dose.

For 10 ml of the drug (not less than 60 doses) in plastic bottle pump metering device with tip and protective cap from polyethylene.

One bottle together with the instructions for application is placed in cardboard pack.

Contrast agent for MRI

The solution for intravenous administration is 0.5 mmol / ml.

hypnotic.
Long-acting tablets 2.0 mg. For 21 tablets in a blister of PVC / PVDC / AL foil. For 1 blister together with instructions for use in a pack of cardboard.
Antihypertensive drug combined (blocker of "slow" calcium channels + inhibitor of angiotensin-converting enzyme
Tablets, 20 mg + 10 mg.
Vitamin - calcium-phosphorus exchange regulator
Drops for oral administration.
Vitamin - calcium-phosphorus exchange regulator

Solution for intravenous administration.

Vitamin - calcium-phosphorus exchange regulator
Capsules 0.25 μg, 1.0 μg.